Abstract
In addition to an altered dopaminergic input, the striatum of the weaver mutant mouse (wv/wv) has increased serotonin tissue content and uptake compared to the wild-type mouse (+/+). To gain information regarding the functional status of serotonergic inputs to thewv/wv striatum, endogenous serotonin release fromwv/wv and +/+ striatum was measured under basal conditions as well as in the presence of fenfluramine or elevated concentrations of potassium (K+). Fractional basal release of serotonin from the +/+ striatum was significantly greater than that from thewv/wv striatum. In the presence of K+, evoked release (stimulated release minus basal release) was greater from the +/+ striatum than from thewv/wv striatum. In the presence of fenfluramine, evoked serotonin release was greater from thewv/wv striatum compared to the +/+ striatum. These data are consistent with the involvement of an additional transmitter(s) in modulating serotonin release to a greater extent in thewv/wv than the +/+ striatum. The data on fenfluramine-stimulated serotonin release suggest that the additional serotonin content found in thewv/wv striatum is in a releasable pool but that striatal serotonin release might be attenuated more inwv/wv than in +/+ mice.
Similar content being viewed by others
References
Schmidt, M. J., Sawyer, B. D., Perry, K. W., Fuller, R. W., Foreman, M. M., and Ghetti, B. 1982. Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2:376–380.
Roffler-Tarlov, S., and Graybiel, A. M. 1984. Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum. Nature 307:62–66.
Roffler-Tarlov, S., Pugatch, D., and Graybiel, A. M., 1990. Patterns of cell and fiber vulnerability in mesostriatal system of the mutant mouse wwaver. II. High affinity uptake sites for dopamine. J. Neurosci. 10:734–740.
Richter, J. A., Stotz, E. H., Ghetti, B., and Simon., J. R. 1992. Comparison of alterations in tyrosine hydroxylase, dopamine levels, and dopamine uptake in the striatum of the weaver mutant mouse. Neurochem. Res. 17:437–441.
Triarhou, L. C., Norton, J., and Ghetti, B. 1988. Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res. 70:256–265.
Stotz, E. H., Triarhou, L. C. Ghetti, B., and Simon, J. R. 1993. Serotonin content is elevated in the dopamine deficient striatum of the weaver mutant mouse. Brain Res. 606:267–272.
Doucet, G., Brundin P., Seth, S., Murata, Y., Strecker, R. E., Triarhou, L. C., Ghetti, B., and Björklund, A. 1989. Degeneration and graft-induced restoration of dopamine innervation in the weaver mouse neostriatum: a quantitative radiographic study of [3H] dopamine uptake. Exp. Brain Res. 77:552–568.
Graybiel, A. M., Ohta, K., and Roffler-Tarlov, S. 1990. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments. J. Neurosci. 10:720–733.
Kaseda, Y., Ghetti, B., Low, W. C., Norton, J., Brittain, H., Triarhou, L. C., Richter, J. A., and Simon, J. R. 1990. Age-related changes in striatal dopamine D2 receptor binding in weaver mice and effects of ventral mesencephalic grafts. Exp. Brain Res. 83:1–8.
Kaseda, Y., Ghetti, B., Low, W. C., Richter, J. A., and Simon, J. R. 1987. Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice. Brain Res. 422:178–181.
Pullara, J. M., and Marshall, J. F. 1989. Striatal dopamine innervation and receptor density: regional effects of the weaver mutation. Brain Res. 480:225–233.
Roffler-Tarlov, S., and Graybiel, A. M. 1986. Expression of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and nonstriatal regions J. Neurosci. 6:3319–3330.
Roffler-Tarlov, S., and Graybiel, A. M. 1987. The postnatal development of the dopamine-containing innervation of dorsal and ventral striatum: effects of the weaver gene. J. Neurosci. 7:2364–2372.
Stotz, E. H., Palacios, J. M., Landwehrmeyer, B., Norton, J., Ghetti, B., Simon, J. R., and Triarhou, L. C. 1994. Alterations in dopamine and serotonin uptake systems in the striatum of the weaver mutant mouse. J. Neural Trans. 97:51–64.
Mennini, T., Borroni, E., Samanin, R., and Garattini, S. 1981. Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem. Int. 3:289–294.
Maura, G., Gemignani, A., Versace, P., Martire, M., and Raiteri, M. 1982. Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings. Neurochem. Int. 4:219–224.
Gobbi, M., Frittoli, E., Mennini, T., and Garattini, S. 1992. Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H] serotonin. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1–6.
Fuller, R. W., Snoddy, H. D., and Robertson, D. W. 1988. Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus release. Pharmacol. Biochem. Behav. 30:715–721.
Simon, J. R., Yu, H., Richter, J. A., Vasko, M. K., and Ghetti, B. 1991. In vivo release of endogenous dopamine from the striatum of the weaver mutant mouse. J. Neurochem. 57:1478–1482.
Becquet, D., Faudon, M., and Héry, F. 1989. In vivo evidence for acetylcholine control of serotonin release in the cat caudate nucleus: Influence of halothane anaesthesia. Neurosci. 27:819–826.
Becquet, D., Faudon, M., and Héry, F. 1990. In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: Involvement of GABA neurons. Brain Res. 519:82–88.
Passarelli, F., and Costa, T. 1989. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus. J. Pharmacol. Exp. Ther. 248:299–305.
Chuluyan, H. E., Rosenstein, R. E., and Cardinali, D. P. 1989. Serotonin release mechanisms in bovine pineal gland: Stimulation by norepinephrine and dopamine. Mol. Cell. Endocrin. 64:71–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stotz-Potter, E.H., Ghetti, B. & Simon, J.R. Endogenous serotonin release from the dopamine-deficient striatum of the weaver mutant mouse. Neurochem Res 20, 821–826 (1995). https://doi.org/10.1007/BF00969694
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969694